CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Authors
Lea Jessica Albrecht
Carola Berking
+21 more
Florentia Dimitriou
Reinhard Dummer
Michael Erdmann
Andrea Forschner
Piyush Grover
Jessica C Hassel
Douglas B Johnson
Frederik Krefting
Elisabeth Livingstone
Georg Lodde
Georgina V Long
Alexander M Menzies
Jan Malte Placke
Christoph Pöttgen
Alexander Roesch
Dirk Schadendorf
Carsten Schulz
Selma Ugurel
Renáta Váraljai
Anne Zaremba
Lisa Zimmer
Publication date
1 May 2024
Publisher
Elsevier
Doi
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
ZORA
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:www.zora.uzh.ch:258671
Last time updated on 20/06/2024
